# A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis

> **NCT06080048** · PHASE1 · COMPLETED · sponsor: **Sorriso Pharmaceuticals, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** SOR102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06080048
- **Lead sponsor:** Sorriso Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-24
- **Primary completion:** 2024-10-16
- **Final completion:** 2024-11-08
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06080048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06080048, "A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06080048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*